Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Responders”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Post-approval studies (Phase 4)UnknownNCT00417183
What this trial is testing

Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation

Who this might be right for
Infertility
Eugonia 300
Post-approval studies (Phase 4)Study completedNCT00115219
What this trial is testing

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

Who this might be right for
Rheumatoid Arthritis
Amgen 200
Testing effectiveness (Phase 2)Study completedNCT00134394
What this trial is testing

Etanercept With Tacrolimus for Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 20
Testing effectiveness (Phase 2)Study completedNCT01888874
What this trial is testing

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 599
Post-approval studies (Phase 4)Active Not RecruitingNCT05108558
What this trial is testing

Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders

Who this might be right for
Peyronie's Disease
Charitable Union for the Research and Education of Peyronie's Disease 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06873945
What this trial is testing

2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 550
Testing effectiveness (Phase 2)Looking for participantsNCT06999980
What this trial is testing

Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

Who this might be right for
Cutaneous MelanomaMucosal Melanoma
Melanoma Institute Australia 494
Large-scale testing (Phase 3)Study completedNCT02293902
What this trial is testing

A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)

Who this might be right for
Rheumatoid Arthritis
Sanofi 243
Not applicableStudy completedNCT05718583
What this trial is testing

Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders

Who this might be right for
Rheumatoid Arthritis
NYU Langone Health 20
Large-scale testing (Phase 3)Study completedNCT01412944
What this trial is testing

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 43
Not applicableStudy completedNCT02354963
What this trial is testing

Follicular Activation in Poor Responders

Who this might be right for
Infertility
César Díaz García 34
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Testing effectiveness (Phase 2)Ended earlyNCT01569074
What this trial is testing

Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 163
Testing effectiveness (Phase 2)Ended earlyNCT01636843
What this trial is testing

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate

Who this might be right for
InflammationRheumatoid Arthritis
Novo Nordisk A/S 298
Large-scale testing (Phase 3)Not Yet RecruitingNCT07346235
What this trial is testing

150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial

Who this might be right for
Infertility, Female
American Hospital 2 Kosovo 440
Large-scale testing (Phase 3)Study completedNCT02990286
What this trial is testing

Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases

Who this might be right for
Lung Disease, Interstitial
University Hospital, Tours 122
Not applicableStudy completedNCT06371989
What this trial is testing

Vacuum Assisted Biopsy and Surgery Correlation in HER2 and TN Breast Cancer Subtypes MRI Responders After Neoadjuvant Therapy: BISUCO TRIAL

Who this might be right for
Breast CancerBreast Biopsy
Hospital Universitario 12 de Octubre 25
Post-approval studies (Phase 4)Looking for participantsNCT05270733
What this trial is testing

Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics

Who this might be right for
Psoriasis
University Hospitals Cleveland Medical Center 56
Not applicableStudy completedNCT04834609
What this trial is testing

Adipose Derived Mesenchymal Stem Cell Characteristics in Anal Fistulas

Who this might be right for
Perianal FistulaAdipose TissueTissue Transplantation
University of Aarhus 27
Not applicableLooking for participantsNCT03740503
What this trial is testing

Genomic Investigation of Unusual Responders

Who this might be right for
CancerBreast CancerNon-small Cell Lung Cancer+8 more
University Health Network, Toronto 100
Load More Results